Broadleaf Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-24,812
| Closed | -$8.59M | – | 74 |
|
|
2021
Q2 | $8.59M | Sell |
24,812
-706
| -3% | -$244K | 2.99% | 8 |
|
|
2021
Q1 | $7.14M | Buy |
25,518
+947
| +4% | +$265K | 2.69% | 10 |
|
|
2020
Q4 | $6.02M | Buy |
24,571
+40
| +0.2% | +$9.79K | 2.37% | 14 |
|
|
2020
Q3 | $6.96M | Buy |
24,531
+3,688
| +18% | +$1.05M | 3.07% | 8 |
|
|
2020
Q2 | $5.58M | Buy |
20,843
+193
| +0.9% | +$51.6K | 2.73% | 12 |
|
|
2020
Q1 | $6.53M | Sell |
20,650
-158
| -0.8% | -$50K | 4.21% | 6 |
|
|
2019
Q4 | $6.17M | Buy |
20,808
+4,085
| +24% | +$1.21M | 3.38% | 10 |
|
|
2019
Q3 | $3.89M | Buy |
+16,723
| New | +$3.89M | 2.43% | 18 |
|
|
2019
Q1 | – | Sell |
-9,763
| Closed | -$2.94M | – | 53 |
|
|
2018
Q4 | $2.94M | Sell |
9,763
-169
| -2% | -$50.9K | 2.35% | 21 |
|
|
2018
Q3 | $3.51M | Buy |
9,932
+1,899
| +24% | +$671K | 2.35% | 16 |
|
|
2018
Q2 | $2.33M | Sell |
8,033
-5,833
| -42% | -$1.69M | 1.71% | 28 |
|
|
2018
Q1 | $3.8M | Buy |
13,866
+5,902
| +74% | +$1.62M | 2.92% | 12 |
|
|
2017
Q4 | $2.54M | Buy |
+7,964
| New | +$2.54M | 2.11% | 22 |
|